Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPPL1 | O15357 | 2/20 | 0.47 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.47 |
| ▸ | INPP5B | P32019 | 1/20 | 0.47 |
| ▸ | SRC | P12931 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | ALPG | P10696 | 1/20 | 0.40 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | PPM1D | O15297 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 3/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4445999 | 0.87 | HPGD (0.41) | HPGDSMN1; SMN2TSHRHSP90AA1HRH1 | |
| SCHEMBL1099381 | 0.87 | SRC (0.51) | INPPL1INPP5AINPP5BSRCHPGD | |
| Phosphoric Acid SCHEMBL28329170 | 0.81 | DRD1 (0.42) | HPGDKDM4EALPGPTK2BSMN1; SMN2 | |
| Ether SCHEMBL8746887 | 0.80 | SRC (0.37) | INPPL1INPP5AINPP5BSRCHPGD | |
| SCHEMBL29965134 | 0.80 | INPPL1 (0.46) | INPPL1INPP5AINPP5BSRCHPGD | |
| SCHEMBL7033288 | 0.79 | HPGD (0.49) | HPGDSMN1; SMN2TSHRHRH1DRD2 | |
| Sulfuric Acid SCHEMBL30659040 | 0.78 | TP53 (0.42) | HPGDSMN1; SMN2TSHRHSP90AA1HRH1 | |
| SCHEMBL18529842 | 0.77 | KDM4E (0.40) | INPPL1INPP5AINPP5BSRCHPGD | |
| SCHEMBL15559464 | 0.77 | SRC (0.51) | SRCHPGDALPGPTK2BSMN1; SMN2 | |
| Ethylene SCHEMBL28237007 | 0.76 | HPGD (0.46) | HPGDSMN1; SMN2TSHRHRH1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115725123-A | Method for incorporating graphene into rubber complexes using a liquid plasticizer route-LPR method | 福特全球技术公司 | 2023-03-03 | — | — | CN | claimed |
| US-20120015908-A1 | SYNTHESIS AND ANTICANCER ACTIVITY OF ARYL AND HETEROARYL-QUINOLIN DERIVATIVES | Efficient Pharma Management Corporate (TW) | 2012-01-19 | — | — | US | claimed |
| CN-115485316-A | Polyol block copolymers | 艾柯尼克技术有限公司 | 2022-12-16 | — | — | CN | disclosed |
| EP-3112348-A1 | SYNTHESIS AND ANTICANCER ACTIVITY OF ARYL AND HETEROARYL-QUINOLIN DERIVATIVES | Tairx, Inc. (TW) | 2017-01-04 | — | — | EP | disclosed |
| US-20090027586-A1 | Thermoplastic Resin Composition, and Liquid Crystal Display Component Thereof or Information Recording Media Component Thereof | POLYPLASTICS CO., LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1992666-A1 | THERMOPLASTIC RESIN COMPOSITION AND LIQUID CRYSTAL DISPLAY PART OR INFORMATION RECORDING MEDIUM PART USING THE COMPOSITION | Polyplastics Co., Ltd. (JP) | 2008-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015908-A1 | SYNTHESIS AND ANTICANCER ACTIVITY OF ARYL AND HETEROARYL-QUINOLIN DERIVATIVES | SLC22A8, ABCC8, CYP2C8 | INPPL1 2278/4885INPP5A 4150/4885INPP5B 3972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.